Haleon, the world’s largest independent consumer health company, is planning significant job cuts in the UK and globally, according to a report by The Guardian.
The company, which was separated from GSK last year, currently employs over 24,000 employees worldwide. The workforce reduction was communicated to employees during meetings this week, and a consultation process has been initiated which is set to conclude on August 25.
Haleon has expressed its commitment to supporting impacted employees during the consultation process. According to the report, those affected by the layoffs are projected to leave the company in September. The specific number of job cuts has not been disclosed yet.
Haleon, which operates in the consumer health sector, is known for brands such as Sensodyne toothpaste and Advil painkillers. The decision to downsize its workforce comes as part of the company’s broader strategic initiatives to adapt to market dynamics and enhance its operational efficiency.
The move is an indication of the ongoing challenges faced by large corporations in the current business landscape, which often necessitate organisational restructuring to remain competitive and achieve long-term growth.
